期刊文献+

葡萄糖转运蛋白1在子宫颈腺癌组织中的表达及其意义 被引量:1

Expression of Gult-1 in cervical adenocarcinoma and its significance
原文传递
导出
摘要 目的 研究葡萄糖转运蛋白1(Gult-1)在子宫颈腺癌组织中的表达及预后分析.方法 运用免疫组织化学(EnVision)法检测Gult-1在子宫颈腺癌组织及癌旁组织中的表达.结果 在癌旁组织、子宫颈腺癌组织中,Gult-l的阳性表达率分别为2.22%(1/45)、58.67%(44/75),两组之间差异有统计学意义(x2=38.23,P=0.00);Gult-1的阳性表达率与患者年龄、组织学分类及浸润深度无关,差异均无统计学意义(均P>0.05):Gult-1的阳性表达率与肿瘤直径、组织学分级及淋巴结转移有关,差异均有统计学意义(均P< 0.05).Gult-1蛋白阳性表达患者生存率低于阴性表达,差异有统计学意义(x 2=4.27,P=0.04).结论 子宫颈腺癌组织中Gult-1的过表达预示癌组织分化低、淋巴结转移可能性大及患者预后不良. [Abstract] Objective To study the expression of Guh-1 in cervical adenocarcinoma and prognosis analysis. Methods Gult-1 was detected by immunohistochemistry (EnVision) in cervical adenocarcinoma and cancer adjacent tissue. Results In cancer adjacent tissue and cervical adenocarcinoma, the positive rates of Guh-1 were 2.22 % (1/45), 58.67 % (44/75), respectively, and there was statistical significance between them (X2 = 38.23, P = 0.00). The expression of Guh-1 was not correlated to age, histological classification and infiltrated depth (all P 〉 0.05). However, it was correlated to tumor size, histological grade and lymphatic nodes metastasis (all P 〈 0.05). The survival rate of positive Gult-1 patients was lower than negative Gult-1 patients (X 2 = 4.27, P = 0.04). Conclusion The over-expression of Gult-1 in cervical adenocarcinoma indicates poorly differentiated cancer, the possibility of lymphatic nodes metastasis and unfavourable prognosis.
机构地区 解放军
出处 《肿瘤研究与临床》 CAS 2014年第1期39-41,共3页 Cancer Research and Clinic
关键词 子宫颈肿瘤 葡萄糖转运蛋白1 预后 Uterine cervical neoplasms Gult-1 Prognosis
  • 相关文献

参考文献11

二级参考文献71

  • 1朱宏,施瑞华.缺氧诱导因子与肿瘤血管生成[J].国外医学(肿瘤学分册),2004,31(8):591-594. 被引量:21
  • 2李向东.乳腺癌组织中C-erbB-2蛋白和MHCⅠ类分子表达与预后的关系[J].实用癌症杂志,2005,20(4):348-350. 被引量:5
  • 3董春花,李福琴,原丹丹,刘倩.GLUT1、VEGF在上皮性卵巢癌中的表达和意义[J].哈尔滨医科大学学报,2006,40(5):379-381. 被引量:4
  • 4Tian H, Hammer RE, Matsumoto AM, et al. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev, 1998,12(21 ): 3320-3324.
  • 5Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol,2000, 157(2) :411-421
  • 6Gu YZ, Moran SM, Hogenesch JB, et al. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr, 1998, 7(3):205-213.
  • 7Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxiainducible factor lalpha in common human cancers and their metastases.Cancer Res, 1999, 59(22) :5830-5835
  • 8Na X, Wu G, Ryan CK, et al. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas. J Urol, 2003, 170(2 Pt 1):588-592.
  • 9Liu MY, Pcellinger L, Walker CL. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Cancer Res, 2003,63 (10): 2675-2680.
  • 10Mizukami Y, Li J, Zhang X, et al. Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res, 2004, 64(5): 1765-1772.

共引文献106

同被引文献7

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部